Dr. Deepa Jagadeesh, M.D.
Internal Medicine (Internal Medicine Physician)
119 Belmont St, Dept Of Hospital Medicine
Worcester, MA 01605
Who else practices at this address →
Worcester County includes primary care (3% of residents) and mental health (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 30
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 178
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
MA license 235844
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cleveland Clinic Cleveland, OH
- Hillcrest Hospital Mayfield Heights, OH
- Akron General Medical Center Akron, OH
- Fairview Hospital Cleveland, OH
- Mercy Medical Center Canton, OH
Medical groups
- Cleveland Clinic (7,090 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 178
- Services billed
- 627
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 249 | 45 |
| Established patient office or other outpatient visit, 40-54 minutes | 134 | 64 |
| Established patient office or other outpatient visit, 30-39 minutes | 100 | 76 |
| New patient office or other outpatient visit, 60-74 minutes | 28 | 28 |
| Established patient office or other outpatient visit, 20-29 minutes | 26 | 26 |
| Hospital discharge day management, 30 minutes or less | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Acyclovir Other prescribers in Worcester, MA | 85 |
| Prednisone Other prescribers in Worcester, MA | 70 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Worcester, MA | 48 |
| Gabapentin Other prescribers in Worcester, MA | 30 |
| Ondansetron Hcl Other prescribers in Worcester, MA | 27 |
| Calquence (acalabrutinib maleate) | 24 |
| Prochlorperazine Maleate Other prescribers in Worcester, MA | 21 |
| Methotrexate (methotrexate sodium) Other prescribers in Worcester, MA | 20 |
| Brukinsa (zanubrutinib) | 20 |
| Jaypirca (pirtobrutinib) | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 24 payments worth $20,211 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $10,983 |
|---|---|
| Regeneron Pharmaceuticals, Inc. | $5,094 |
| Genmab U.S., Inc. | $3,473 |
| Celgene Corporation | $414 |
| Pfizer Inc. | $207 |
| Kyowa Kirin, Inc. | $39.71 |
| Consulting Fee | $18,249 |
|---|---|
| Travel and Lodging | $1,208 |
| Food and Beverage | $754 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Nov 10, 2025 | Consulting Fee | $10,983 |
| Regeneron Pharmaceuticals, Inc. Aug 22, 2025 | Consulting Fee | $3,324 |
| Genmab U.S., Inc. May 19, 2025 | Consulting Fee Epkinly · Oncology | $2,280 |
| Regeneron Pharmaceuticals, Inc. Aug 22, 2025 | Consulting Fee | $1,454 |
| Genmab U.S., Inc. Mar 7, 2025 | Travel and Lodging Epkinly · Oncology · travel to Arlington, VA · in-kind | $876 |
| Regeneron Pharmaceuticals, Inc. Aug 22, 2025 | Consulting Fee | $208 |
| Celgene Corporation Sep 24, 2025 | Travel and Lodging travel to Lawrenceville Township, NJ | $189 |
| Celgene Corporation Sep 25, 2025 | Travel and Lodging travel to Lawrence, NJ | $68.05 |
| Celgene Corporation Sep 25, 2025 | Travel and Lodging travel to Lawrence, NJ | $59.54 |
| Genmab U.S., Inc. May 19, 2025 | Travel and Lodging Epkinly · Oncology · travel to Arlington, VA | $15.97 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $239,218 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
Regeneron Pharmaceuticals, Inc. · Active, not recruiting · NCT03888105 - A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Eli Lilly and Company · Completed · NCT03740529
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.